VAIOMER
  • VAIOMER
    • About VAIOMER
    • Contamination-aware approach
    • Microbiome discovery timeline
    • Microbiome analysis services
    • News
  • ABOUT MICROBIOME
    • Definitions
    • Translational research
    • Bacterial translocation
    • Atlas of microbiomes
  • MICROBIOME APPLICATIONS
    • Skin microbiome
    • Cardio-metabolic diseases
    • Liver diseases
    • Gastrointestinal disorders
    • Cancer
    • Neurodegenerative and mental disorders
    • COVID & Infectious diseases
    • Autoimmune and inflammatory diseases
    • Nutrition
    • Kidney diseases
    • Microbiome in early life
  • RESOURCES
  • CONTACT
  • #
  • #
Select Page
Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum: Europe

Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum: Europe

by microbiome | Oct 21, 2021 | Highlights, News

Vaiomer is honored to sponsor the Microbiome R&D and Business Collaboration Forum in Rotterdam on October 26 and 27 Vaiomer’s representatives, Anne DEFLISQUE (Sales & Marketing Director), Céline RIBIERE (Microbiome Scientist) and Florence SERVANT (Head of...
Vaiomer is honored to sponsor the 8th IHMC Congress

Vaiomer is honored to sponsor the 8th IHMC Congress

by microbiome | Jun 10, 2021 | Highlights, News

Vaiomer is happy to announce that we will be attending the 8th IHMC Virtual Congress 2021 on June 27, 28 & 29 Vaiomer is looking forward to catching up on the latest scientific developments in the microbiome field. We are delighted by the opportunity to exchange...
Circulating microbiome: controlling contamination for reliable data

Circulating microbiome: controlling contamination for reliable data

by microbiome | Jan 2, 2021 | Highlights, Vaiomer original work

Circulating microbiome advances rely on strong contamination-aware metagenomics using negative controls Schierwagen and colleagues (2019) described the circulating microbiome from different compartments accessible during the implantation of a transjugular intrahepatic...
Bacterial translocation and tissue microbiomes: Vaiomer founding work

Bacterial translocation and tissue microbiomes: Vaiomer founding work

by microbiome | Jan 1, 2021 | Highlights, Vaiomer original work

The role of bacterial translocation in diabetes and the characterization of healthy tissue microbiota A plethora of studies has associated the intestinal microbiota with numerous diseases including obesity and type 2 diabetes (T2D). Obesity is characterized by...
Next Entries »

Research

Categorie

  • Highlights (32)
  • Microbiomes & cancer (5)
  • Microbiomes & Metabolism (9)
  • News (15)
  • Skin Microbiome (1)
  • Vaiomer original work (17)

Archives

  • Cross-Influence of Tick and Host Skin Microbiomes During Tick Bites: A New Frontier in Understanding Pathogen Transmission
  • Vaiomer will be attending «Journées Polepharma de Microbiomique, 4ème édition»
  • Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»
  • Vaiomer is participating in the Genotoul Scientific Day-HOLOBIONTES
  • Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release

516, rue Pierre et Marie Curie
31670 Labège, France
Tel : +33 (0)5 61 28 71 66
Fax : +33 (0)5 61 28 71 68
Contact us !

 

About Vaiomer :

Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases.

 

Follow us !

Vaiomer ©  – Legal Notice and Privacy Policy and GDPR conditions– Conception by Comm’IN

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.